Background: Prenatal screening in Norway is governed by the Biotechnology Act. According to the Act, which was adopted in 2003, prenatal screening in early pregnancy may only be offered to women with an elevated risk of having a child with chromosomal abnormalities or malformations. This type of prenatal screening is undertaken at fetal medicine centres.
View Article and Find Full Text PDF